Article
Genomic profiling of cancerous patients identifies FPR2 as an alternative immunotherapeutic target in glioblastoma multiforme
2020-12-27
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Glioblastoma multiforme (GBM) is a type of high-grade brain tumor known for its proliferative, invasive property, and low survival rate. Recently, with the advancement in therapeutics for tumors such as targeted therapy, individual cancer-specific biomarkers could be recognized as targets for curative purposes. This study identified six differentially expressed genes that ha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d6e48026-2f67-572f-b859-e54bc298d365
- DOI
- 10.1101/2020.12.26.424414
